Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device

7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Radiation therapy is a useful and standard tumor treatment strategy. Despite recent advances in delivery of ionizing radiation, survival rates for some cancer patients are still low because of recurrence and radioresistance. This is why many novel approaches have been explored to improve radiotherapy outcome. Some strategies are focused on enhancement of accuracy in ionizing radiation delivery and on the generation of greater radiation beams, for example with a higher dose rate. In the present study we proposed an in vitro research of the biological effects of very high dose rate beam on SK-Mel28 and A375, two radioresistant human melanoma cell lines. The beam was delivered by a pulsed plasma device, a “Mather type” Plasma Focus for medical applications. We hypothesized that this pulsed X-rays generator is significantly more effective to impair melanoma cells survival compared to conventional X-ray tube. Very high dose rate treatments were able to reduce clonogenic efficiency of SK-Mel28 and A375 more than the X-ray tube and to induce a greater, less easy-to-repair DNA double-strand breaks. Very little is known about biological consequences of such dose rate. Our characterization is preliminary but is the first step toward future clinical considerations.

Cite

CITATION STYLE

APA

Buontempo, F., Orsini, E., Zironi, I., Isolan, L., Cappellini, A., Rapino, S., … Castellani, G. (2018). Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device. PLoS ONE, 13(6). https://doi.org/10.1371/journal.pone.0199312

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free